Lung Cancer Screening: A Decade of Lessons Learned with Mary Pasquinelli, DNP
It has been more than a decade since lung cancer screening guidelines via low-dose CT, based on the USPSTF’s B recommendations, have been put into place. To discuss the guidelines’ ambitions and obstacles, we are joined by the University of Illinois Health System’s Mary Pasquinelli, DNP, who specializes in lung cancer, lung cancer screening and pulmonary nodule management. While a lifesaving procedure for at-risk individuals, the uptake of screening on a population-level—though increasing—has been slower than expected.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
--------
35:36
After the Smoke: Wildfire Cleanup & Air Quality Concerns with Afif El-Hasan, MD
For this hot topic, asthma and lung health expert Dr. Afif El-Hasan of Kaiser Permanente in California joins host Dr. Albert Rizzo to discuss the acute effects of wildfire smoke on air quality. The enlightening conversation also covers the massive cleanup efforts from the recent Los Angeles wildfires and how related exposures may pose health risks.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
--------
14:50
Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
In this episode, Dr. Meredith McCormack of Johns Hopkins University and Dr. Loretta Que of Duke University to discuss “race-based normal values” in medicine, particularly in regard to pulmonary function tests (PFT).
The controversial practice of using a patient’s self-reported race to adjust a standard “normal” range has been shown to lead to potential misdiagnosis and healthcare disparities. Drs. McCormack and Que talk at length about their key roles in the growing movement to phase out a reliance on race in PFT interpretation.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
--------
20:53
This Year in Pulmonology: The 2024 Lungcast Recap
Ever since the show first launched, Lungcast has provided pulmonologists and health care providers in general a chance to take part in ongoing conversations regarding lung health between experts, patients, and patient advocates.
In this recap episode, the Lungcast team reflects on these conversations by highlighting some of the many interviews featured in 2024. The following are a set of examples of this year’s interviews, though several other memorable episodes are not on this list. We hope you enjoy this set of highlights.
For more, view a summary here: https://www.hcplive.com/view/this-year-in-pulmonology-a-2024-lungcast-recap
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
--------
18:58
2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targeted mutations, Dr. Sands addresses how precision oncology is fundamentally changing lung cancer diagnosis and treatment.
The novel immunotherapy drugs, though proven to be safe and effective with significant improvements in response and survival rates, have challenges as well—this episode covers the gamut.
Episode Highlights
0:00 Start
1:00 Topic of discussion
2:42 Introducing Jacob Sands, MD
3:39 NCCN guidelines for lung cancer
6:51 Recently-approved drugs for lung cancer
13:46 Patient responses to targeted mutations
17:58 Off-target side effects with drugs
21:34 State of Lung Cancer report
23:04 Estimated number of candidates for targeted therapies
26:13 Insurance coverage for biomarker testing
28:12 Other issues with ordering biomarkers
31:20 Closing comments
32:36 Outro
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Join the American Lung Association and HCPLive every month as Dr. Al Rizzo interviews world-leading experts on the great challenges, accomplishments, and stories in respiratory medicine.
Get the latest lung health news, including future Lungcast topics and guests, by signing up for our newsletter at Lung.org. (https://www.lung.org)
Australia